CD8A and neoplasm: The survival benefit was further enhanced in patients with CD3+CD8- T cells in the stroma co-occurring with CD3+CD8+ (cytotoxic) T cells in the tumour epithelium, consistent with CD8+ T cell activation supported by regional support from helper T cells.